<DOC>
	<DOC>NCT01579955</DOC>
	<brief_summary>This study is conducted in Japan. The aim of this non-interventional study is to investigate the safety and effectiveness of treatment with eptacog alpha (NovoSeven速) under normal clinical practice conditions.</brief_summary>
	<brief_title>Non-Interventional Study of NovoSeven速 Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patients with haemophilia A and B with inhibitors who received eptacog alpha (NovoSeven速) as treatment Patients who was not deemed to be appropriate to the treatment of eptacog alpha (NovoSeven速)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>